PEAK6 Group’s CONMED CNMD Stock Holding History

PEAK6 Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$937K	Buy	12,800 +7,200	+129%	+$490K	﹤0.01%	2015
2018 Q1	$355K	Buy	5,600 +4,600	+460%	+$275K	﹤0.01%	2897
2017 Q4	$51K	Sell	1,000 -60,100	-98%	-$3.13M	﹤0.01%	3739
2017 Q3	$3.21M	Buy	61,100 +52,400	+602%	+$2.63M	0.02%	1042
2017 Q2	$443K	Buy	+8,700	New	+$430K	﹤0.01%	2647
2017 Q1	–	Sell	-1,300	Closed	-$57K	–	4385
2016 Q4	$57K	Hold	1,300	–	–	﹤0.01%	4153
2016 Q3	$52K	Sell	1,300 -3,700	-74%	-$157K	﹤0.01%	3862
2016 Q2	$239K	Sell	5,000 -5,000	-50%	-$212K	﹤0.01%	3007
2016 Q1	$419K	Buy	10,000 +5,600	+127%	+$220K	﹤0.01%	2440
2015 Q4	$194K	Hold	4,400	–	–	﹤0.01%	3465
2015 Q3	$210K	Sell	4,400 -1,800	-29%	-$98.8K	﹤0.01%	3698
2015 Q2	$361K	Buy	+6,200	New	+$334K	﹤0.01%	3115
2014 Q2	–	Sell	-2,000	Closed	-$87K	–	4652
2014 Q1	$87K	Buy	+2,000	New	+$89.1K	﹤0.01%	4027

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PEAK6 Group's CNMD Position: Q1 2018 in Review

PEAK6 Group sold out of CONMED (CNMD) in Q1 2018, closing a stake of 761 shares — an estimated $45.4K sold.

PEAK6 Group first reported a position in CNMD in Q1 2014 and held it in 5 quarters. The position peaked at $496K in Q1 2017. 173 funds tracked by Wall St. Rank hold CNMD as of Q1 2018.

PEAK6 Group reported no remaining CONMED position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 761 CONMED shares in Q1 2018, an estimated $45.4K.
PEAK6 Group first reported a position in CONMED in Q1 2014 and held it in 5 quarters.
PEAK6 Group's CONMED position peaked at $496K in Q1 2017.
173 funds tracked by Wall St. Rank held CONMED as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.